Dashboard
Manage Tickers

TOVXTheriva Biologics, Inc.

NYSE therivabio.com


$ 3.43 $ 0.05 (1.63 %)    

Monday, 26-Aug-2024 10:46:09 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.57 $ -5.36 (-1.12 %)
DIA $ 413.84 $ 0.99 (0.24 %)
SPY $ 561.00 $ -2.19 (-0.39 %)
TLT $ 98.55 $ -0.10 (-0.1 %)
GLD $ 232.74 $ -0.74 (-0.32 %)
$ 0.144
$ 3.38
$ 3.50 x 100
-- x --
$ 3.38 - $ 3.55
$ 0.11 - $ 0.68
22,226,841
na
144,756
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-25-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-16-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 03-04-2021 12-31-2020 10-K
16 11-10-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 02-20-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 02-22-2018 12-31-2017 10-K
28 11-01-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 03-02-2017 12-31-2016 10-K
32 11-01-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 03-10-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-16-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

peering-into-theriva-biologicss-recent-short-interest
Peering Into Theriva Biologics's Recent Sh...
08/20/2024 19:30:14

nasdaq-surges-150-points-sonder-holdings-shares-surge
Nasdaq Surges 150 Points; Sonder Holdings ...
08/19/2024 18:37:19

why-nikola-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Nikola Shares Are Trading Lower By Aro...
08/19/2024 17:37:46

crude-oil-down-2-alzamend-neuro-shares-spike-higher
Crude Oil Down 2%; Alzamend Neuro Shares S...
08/19/2024 16:28:18

dow-jumps-over-100-points-estee-lauder-shares-edge-lower-after-q4-results
Dow Jumps Over 100 Points; Estee Lauder Sh...
08/19/2024 13:56:10

whats-going-on-with-theriva-biologics-tovx-stock
What's Going On With Theriva Biologics (TO...
08/19/2024 13:22:12

Theriva Biologics shares are trading lower by 8.4% Monday morning. The company announced a 1-for-25 reverse stock split.

theriva-biologics-announces-1-for-25-reverse-stock-split-effective-august-26-2024
Theriva Biologics Announces 1-For-25 Rever...
08/16/2024 20:06:03

Theriva Biologics, Inc. (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat diseases in...

theriva-biologics-q2-eps-043-misses-019-estimate
Theriva Biologics Q2 EPS $(0.43) Misses $(...
08/13/2024 12:15:25

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0...

theriva-biologics-announces-fda-grants-rare-pediatric-drug-designation-for-vcn-01-to-treat-retinoblastoma-lead-product-candidate-also-holds-orphan-drug-designation
Theriva Biologics Announces FDA Grants Rar...
07/31/2024 12:27:00

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/11/2024 16:31:11

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/10/2024 20:31:12

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
06/05/2024 20:31:22

theriva-biologics-receives-fda-fast-track-designation-for-vcn-01-in-combination-with-gemcitabine-and-nab-paclitaxel-to-improve-survival-in-metastatic-pancreatic-adenocarcinoma
Theriva Biologics Receives FDA Fast Track ...
05/23/2024 12:20:33

theriva-biologics-shares-are-trading-higher-after-the-fda-granted-fast-track-designation-to-vcn-01
Theriva Biologics shares are trading highe...
05/23/2024 12:17:29

theriva-biologics-reports-183m-in-cash-for-q1-2024-which-is-expected-to-provide-runway-into-the-first-quarter-of-2025
Theriva Biologics Reports $18.3M In Cash F...
05/07/2024 11:15:21

theriva-biologics-q1-2024-gaap-eps-030-misses-027-estimate
Theriva Biologics Q1 2024 GAAP EPS $(0.30)...
05/07/2024 11:14:20

theriva-biologics-files-mixed-securities-shelf
Theriva Biologics Files Mixed-Securities S...
05/02/2024 21:21:18

theriva-biologics-to-discuss-the-trial-design-for-virage---a-phase-2b-clinical-study-of-systemically-administered-vcn-01-in-combination-with-chemotherapy-in-pancreatic-ductal-adenocarcinoma-at-the-2024-asco-annual-meeting
Theriva Biologics To Discuss The Trial Des...
04/25/2024 12:34:38

Theriva™ Biologics (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and relat...

theriva-biologics-disclosed-positive-topline-data-from-investigator-sponsored-phase-1-trial-of-intravitreal-vcn-01-in-pediatric-patients-with-refractory-retinoblastoma
Theriva Biologics Disclosed Positive Topli...
04/23/2024 12:40:08

why-hibbett-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Hibbett Shares Are Trading Higher By 1...
04/23/2024 12:00:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION